Depression during mania: Treatment response to lithium or divalproex

Archives of General Psychiatry

Volumn 54, Issue 1, 1997, Pages 37-42

  Swann, Alan C ^a,h   Bowden, Charles L ^b   Morris, David ^c   Calabrese, Joseph R ^d   Petty, Frederick ^e   Small, Joyce ^f   Dilsaver, Steven C ^a   Davis, John M ^g  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c ABBOTT LABORATORIES   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS AT DALLAS   (United States)

^f INDIANA UNIVERSITY   (United States)

^g UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^h NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM CARBONATE; PLACEBO; VALPROATE SEMISODIUM;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0031012799     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.1997.01830130041008     Document Type: Article

References (23)

1. Prien RF, Himmelhoch JM, Kupfer DJ. Treatment of mixed mania. J Affect Disord. 1988;15:9-15.
2. Secunda S, Katz MM, Swann AC, Koslow SH, Maas JW, Chang S, Croughan J. Mania: diagnosis, state measurement, and prediction of treatment response. J Affect Disord. 1985;8:113-121.
3. Kishimoto A, Ogura C, Hazama H, Inoue K. Long-term prophylactic effects of carbamazepine in affective disorder. Br J Psychiatry. 1983;143:327-331.
4. Kukopoutos A, Caliari B, Tondo A. Rapid cyclers, temperament, and antidepressants. Compr Psychiatry. 1983;24:249-258.
5. Black DW, Winokur G, Hulbert J, Nasrallah A. Predictors of immediate response in the treatment of mania: the importance of comorbidity. Biol Psychiatry. 1988;24:191-198.
6. Faedda GL, Baldessarini RJ, Tohen M, Strakowski SM, Waternaux C. Episode-sequence in bipolar disorder and response to lithium treatment. Am J Psychiatry. 1991;148:1237-1239.
7. McElroy SL, Keck PE, Pope HG Jr, Hudson JI, Faedda GL, Swann AC. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry. 1992;149:1633-1644.
8. Cohen S, Khan A, Cox G. Demographic and clinical features predictive of recovery in acute mania. J Nerv Ment Dis. 1989;177:638-642.
9. Dilsaver SC, Swann AC, Shoaib AM, Bowers TC, Halle MT. Mixed mania associated with nonresponse to antimanic agents. Am J Psychiatry. 1993;150:1548-1551.
10. Post RM, Uhde TW, Roy Byrne PP, Joffe RT. Correlates of antimanic response to carbamazepine. Psychiatry Res. 1987;21:71-83.
11. Calabrese JR, Woysheville MJ, Kasimond SE, Rapport DJ. Predictors of valproate response in bipolar rapid cycling. J Clin Psychopharmacol. 1993;13:280-283.
12. Freeman TW, Clothier JL, Pazzaglia P, Lesern MD, Swann AC. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry. 1992;149:108-111.
13. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG, Garza Trevino ES, Risch SC, Goodnick PJ, Morris DD. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA. 1994;271:918-924.
14. Spitzer RL, Endicott J. Schedule for Affective Disorders and Schizophrenia. 3rd ed. New York, NY: New York State Psychiatric Institute Biometrics Institute; 1978.
15. Spitzer RL Endicott J, Robins E. Research Diagnostic Criteria fora Selected Group of Functional Disorders. 3rd ed. New York, NY: New York State Psychiatric Institute Biometrics Institute; 1978.
16. Spitzer RL, Endicott J. Schedule for Affective Disorders and Schizophrenia: Change Version. 3rd ed. New York, NY: Biometrics Research, New York State Psychiatric Institute; 1978.
17. Murphy DL, Pickar D, Atterman I. Methods for the quantitative assessment of depressive and manic behavior In: Burdoch EI, Sudilovsky A, Gershon S, eds. Quantitative Techniques for the Evaluation of the Behavior of Psychiatric Patients. New York, NY: Marcel Dekker Inc; 1982:355-393.
18. Swann AC, Secunda SK, Katz MM, Koslow SH, Maas JW, Chang S, Robins E. Lithium treatment of mania: clinical characteristics, specificity of symptom change, and outcome. Psychiatry Res. 1986;18:127-141.
19. Swann AC, Secunda SK, Katz MM, Croughan J, Bowden CL, Koslow SH, Berman N, Stokes PE. Specificity of mixed affective states: clinical comparison of mixed mania and agitated depression. J Affect Disord. 1993;28:81-89.
20. Himmelhoch JM, Garfinkel ME. Sources of lithium resistance in mixed mania. Psychopharmacol Bull. 1986;22:613-620.
21. Nunn CMH. Mixed affective states and the natural history of manic-depressive psychosis. Br J Psychiatry. 1979;134:153-160.
22. Small JG, Klapper MH, Kellams JJ, Miller MJ, Milstein V, Sharpley PH, Small IF. ECT compared with lithium in the management of manic states. Arch Gen Psychiatry. 1988;45:727-732.
23. Swann AC, Stokes PE, Casper R, Secunda SK, Bowden CL, Berman N, Katz MM, Robins E. Hypothalamic-pituitary-adrenocortical function in mixed and pure mania. Acta Psychiatr Scand. 1992;85:270-274.